| Date | Acquired company | Acquiring company | Amount | Related |
|---|---|---|---|---|
| 2017-08-29 | Patheon (USA - NC) | Thermo Fisher Scientific (USA - MA) | $7.2 billion | Technology - Services |
| 2017-08-28 | Protein Sciences (USA - CT) | Sanofi (France) | up to $750 million | Vaccines - Infectious diseases |
| 2017-08-28 | Syncom (The Netherlands) | Mercachem (The Netherlands) | CRO - Technology - Services | |
| 2017-08-28 | Natrix Separations (Canada) | Merck KGaA (Germany) | undisclosed | Technology - Services |
| 2017-08-09 | Cempra (USA - NC) | Melinta Therapeutics (USA - CT) | Infectious diseases | |
| 2017-08-04 | Micro-Macinazione (Italy) | Lonza (Switzerland) | undisclosed | Technology - Services |
| 2017-08-03 | IFM Therapeutics (USA - MA) | BMS (USA - NY) | $300 million upfront with potential of up to $1.01 billion in milestones for each of the first products from the two programs | Cancer - Oncology - Autoimmune diseases - Inflammatory diseases |
| 2017-08-01 | BMS’s pharmaceutical manufacturing facility in Bothell (USA -WA ) | Seattle Genetics (USA -WA ) | undisclosed | |
| 2017-07-31 | DiscoverX (USA - CA) | Eurofins Scientific (Luxembourg) | undisclosed | Technology - Services |
| 2017-07-27 | GATC Biotech (Germany) | Eurofins Scientific (Luxembourg) | undisclosed | Technology - Services |
| 2017-07-27 | Mapi Group (France) | Icon (Ireland) | undisclosed | CRO |
| 2017-07-26 | Advinus Therapeutics (India) | Eurofins Scientific (Luxembourg) | undisclosed | Technology - Services |
| 2017-07-20 | Akorn (USA - IL) | Fresenius Kabi (Germany) | $4.75 billion | generics |
| 2017-07-18 | TomTec Imaging Systems (Germany) | Philips (The Netherlands) | undisclosed | Technology - Services |
| 2017-07-17 | Merus Labs International (Canada) | Norgine (The Netherlands) | C$342 million | |
| 2017-07-10 | Amatsigroup (France) | Eurofins Scientific (Luxembourg) | € 130 million | Technology - Services |
| 2017-07-06 | Capsugel (USA - NJ) | Lonza (Switzerland) | $ 5.5 billion | Technology - Services - Bioproduction - Manufacturing |
| 2017-06-30 | mySugr (Austria) | Roche (Switzerland) | undisclosed | diabetes |
| 2017-06-28 | True North Therapeutics (USA - CA) | Bioverativ (USA - MA) | up to $825 million | Genetic diseases - Rare diseases - Hematological disease |
| 2017-06-26 | Innova Biosciences (UK) | Sygnis (Germany) |
